Found 160 results
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is C  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C. Cutler, Stevenson, K., Kim, H. T., Richardson, P., Ho, V. T., Linden, E., Revta, C., Ebert, R., Warren, D., Choi, S., Koreth, J., Armand, P., Alyea, E., Carter, S., Horowitz, M., Antin, J. H., and Soiffer, R., Sirolimus Is Associated With Veno-Occlusive Disease of the Liver After Myeloablative Allogeneic Stem Cell Transplantation, Blood, vol. 112, pp. 4425-4431, 2008.
C. Cutler, Logan, B., Nakamura, R., Johnston, L., Choi, S., Porter, D., Hogan, W., Pasquini, M., MacMillan, M., Wingard, J., Waller, E., Grupp, S., McCarthy, P., Wu, J., Hu, Z., Carter, S., Horowitz, M. M., and Antin, J. H., Tacrolimus/Sirolimus vs. Tacrolimus/Methotrexate for GVHD Prophylaxis After HLA-Matched, Related Donor Hematopoietic Stem Cell Transplantation: Results of BMT CTN Trial 0402, in 54th Annual ASH Meeting, Atlanta, GA, 2012.
C. Cutler, Logan, B., Nakamura, R., Johnston, L., Choi, S., Porter, D., Hogan, W. J., Pasquini, M., MacMillan, M. L., Hsu, J. W., Waller, E. K., Grupp, S., McCarthy, P., Wu, J., Hu, Z. H., Carter, S. L., Horowitz, M. M., and Antin, J. H., Tacrolimus/Sirolimus vs Tacrolimus/Methotrexate as GVHD Prophylaxis After Matched, Related Donor Allogeneic HCT, Blood, vol. 124, pp. 1372-1377, 2014.
M. Cusik, Dahr, S., Srivastava, S., Coleman, H., Thompson, D., and Chew, E., Intravitreal Anti-VEGF Therapy for Advanced Ocular Disease of Von Hippel-Lindau Disease, in Association for Research in Vision and Ophthalmology, Ft. Lauderdale, FL, 2004.
M. Cusick, SanGiovanni, J. P., Chew, E. Y., Reed, G. F., Agron, E., Sperduto, R. D., Clemons, T. E., and Ferris, F. L., The Relationship of Omega(n)-3 Long-Chain Polyunsaturated Fatty Acid (LCPUFA) Intake and Regular Aspirin (ASA) Use with Prevalent Neovascular Age-Related Macular Degeneration, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2005.
M. Cusick, Meleth, A. D., Agron, E., Fisher, M. R., Reed, G. F., Knatterud, G. L., Barton, F. B., Davis, M. D., Ferris, F. L. 3rd, and Chew, E. Y., Associations of Mortality and Diabetes Complications in Patients with Type 1 and Type 2 Diabetes: Early Treatment Diabetic Retinopathy Study Report No. 27, Diabetes Care, vol. 28, pp. 617-625, 2005.
F. Curro, Capstraw, E., Harewood, L., and Sung, A., Identifying Investigators to Conduct Randomized Controlled Trials (RCTs) in a Practice Based Research Network (PBRN), in Inventory and Evaluation of Clinical Research Networks, 2007.
F. A. Curro, Thompson, V. P., Grill, A., Vena, D., Terracio, L., and Naftolin, F., Practice Based Research Networks Impacting Periodontal Care: PEARL Initiative, J Periodontol, vol. 84, pp. 567-571, 2013.
F. Curro, Capstraw, E., Harewood, L., and Sung, A., Practice-Based Research Networks (PBRNs) Maximizing Patient Contact with Pharmacovigilance and Signaling, in Drug Information Association, 2007.
F. A. Curro, Thompson, V. P., Grill, A., Craig, R. G., Botello-Harbaum, M. T., Matthews, A. G., and Collie, D., An Assessment of the Perceived Benefits and Challenges of Participating in a Practice-based Research Network, Prim Dent J, vol. 1, pp. 50-57, 2012.
F. Curro, Thompson, V., Craig, R., and Vena, D., Chapter 14.4: Recruitment and Retention Strategies for Practice-Based Research Network Investigators, in Clinical Research in Oral Health, Hoboken, NJ: Wiley - Blackwell, 2010.
F. Curro, Capstraw, E., Harewood, L., and Sung, A., The Role of Practice Based Research Networks (PBRN) in the Spectrum of Clinical Trials, presented at the 05/2007, 2007.
F. A. Curro, Robbins, D. A., F, N., Grill, A. C., Vena, D., and Terracio, L., Person-Centric Clinical Trials: Defining the N-of-1 Clinical Trial Utilizing a Practice-Based Translational Network, Clin Investig (Lond), vol. 5, no. 2, pp. 145-159, 2015.
F. Curro, Thompson, V. P., Naftolin, F., Grill, A., Vena, D., Terracio, L., Hashimoto, M., Buchholz, M., McKinstry, A., Cannon, D., Alfano, V., Gooden, T., Vernillo, A., and Czeisler, E., Practice-Based Research Network Infrastructure Design for Institutional Review Board Risk Assessment and Generalizability of Clinical Results, Therapeutic Innovation & Regulatory Science, vol. 47, pp. 82-89, 2013.
F. Curro, Thompson, V., Vena, D., Craig, R., Naftolin, F., Buccholz, M., Hashimoto, M., Alfano, V., Cannon, D., Gooden, T., McKinstry, A., Perez, L., and Collie, D., GCP Compliance Supporting Efficacy/Effectiveness Studies, presented at the 22/06/2011, Bethesda, MD, 2011.
F. Curro, Craig, R., Vena, D., and Thompson, V., The Role of Interim Analysis as a Quality Assurance Function in Practice-Based Research Network Clinical Studies, Compend Contin Educ Dent, vol. 30, pp. 352-354, 2009.
F. A. Curro, Vena, D., Naftolin, F., Terracio, L., and Thompson, V. P., The PBRN Initiative: Transforming New Technologies to Improve Patient Care, J Dent Res, vol. 91, pp. S12-S20, 2012.
F. A. Curro, Grill, A. C., Thompson, V. P., Craig, R. G., Vena, D., Keenan, A. V., and Naftolin, F., Advantages of the Dental Practice-Based Research Network Initiative and its Role in Dental Education, J Dent Educ, vol. 75, pp. 1053-1060, 2011.
C. Cukras, Agron, E., Klein, M., ,, Chew, E., Gensler, G., and Wong, W., Natural History of Drusenoid Pigment Epithelial Detachment in Age-Related Macular Degeneration: Age-Related Eye Disease Study Report No. 28, Ophthalmology, vol. 117, pp. 489-499, 2010.
K. Csaky, Phase II Trial of Celebrex in Photodynamic Therapy (C-PDT) for Neovascular Age-related Macular Degeneration (AMD): Rationale and Baseline Characteristics, 2004.
K. Csaky, Blodi, B., Osman, M., Cousin, S., Callanan, D., and Hammel, K., The Utility of Dynamic Indocyanine Green Angiography (D-ICG) in Patients with Neovascular Age-Related Macular Degeneration (AMD) As Determined By Two Prospective Clinical Trials, in The 29th Annual Macula Society Meeting, North San Diego, CA, 2006.
K. Csaky, Blodi, B., Osman, M., Fullmer, K., Callanan, D., and Cousins, S., Phase II Trial of Celecoxib and Photodynamic Therapy (C-PDT) for Neovascular Age-Related Macular Degeneration, in The 28th Annual Macula Society Meeting, Key Biscayne, FL, 2005.
T. A. Crowell, Colby, D. J., Pinyakorn, S., Sacdalan, C., Pagliuzza, A., Intasan, J., Benjapornpong, K., Tangnaree, K., Chomchey, N., Kroon, E., deSouza, M. S., Tovanabutra, S., Rolland, M., Eller, M. A., Paquin-Proulx, D., Bolton, D. L., Tokarev, A., Thomas, R., Takata, H., Trautmann, L., Krebs, S. J., Modjarrad, K., McDermott, A. B., Bailer, R. T., Doria-Rose, N., Patel, B., Gorelick, R. J., Fullmer, B. A., Schuetz, A., Grandin, P. V., OConnell, R. J., Ledgerwood, J. E., Graham, B. S., Tressler, R., ,, Chomont, N., Michael, N. L., Robb, M. L., Phanuphak, N., Ananworanich, J., and Dawson, P., Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial, Lancet HIV, 2019.
A. Crisan, Ghadessi, M., Buerki, C., Vergara, I. A., Thompson, D. J. S., Erho, E., Sierocinski, T., Haddad, Z., Zimmermann, B., Sosu-Sedzorme, W., Harko, S., Black, P. C., Davicioni, E., and Jenkins, R. B., Clinical and Genomic Analysis of Metastatic Disease Progression in a Background of Biochemical Recurrence, in 2012 ASTRO - American Society for Radiation Oncology, Boston, MA, 2012.
P. S. Creticos, Schroeder, J. T., Hamilton, R. G., Balcer-Whaley, S. L., Khattignavong, A. P., Lindblad, R., Li, H., Coffman, R., Seyfert, V., Eiden, J. J., and Broide, D., Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis., N Engl J Med, vol. 355, no. 14, pp. 1445-55, 2006.